Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Are Textbooks Holding Back Cures for Cancer?


News provided by

Natural Code LLC

28 Jul, 2021, 18:13 GMT

Share this article

Share toX

Share this article

Share toX

Famed Researchers Highlight Glaring Omissions About the Power of Our Cells

Say Modernizing What We Teach About Our Ability To Influence Evolution Can Change How Medicine Is Practiced

OXFORD, England, July 28, 2021 /PRNewswire/ -- Misunderstandings and omissions from Charles Darwin's theory of evolution have spawned massive failures in cancer, antibiotics and nutrition – and it's time to rediscover the real Darwin. That's the view of famed Oxford scientist Denis Noble, creator of the first 3-D model of the heart, longtime author on evolutionary change and scientific advisor to the $10 Million Evolution 2.0 Prize created by biotech company Natural Code LLC.

Continue Reading
This image opens in the lightbox
Famed Oxford Scientist Denis Noble stands next to a bust of Charles Darwin on the Galápagos Islands, where Darwin developed his Theory of Evolution. Noble believes textbooks have omitted much of Darwin’s original work and says correcting how evolution is taught holds they key to curing diseases. (PRNewsfoto/Natural Code LLC)
This image opens in the lightbox
View PDF
“What Popular Evolution Books Ignore”

Noble is challenging long-standing theories that claim evolution is gradual, when studies now show cancer cells evolve in days. "We will never understand cancer until we recognize how tumors adapt on an hourly basis," offers Noble. "But if we show our pre-med students how the human body directs its own evolutions, it will forever transform how they practice medicine."

That's why researchers around the world (including 70 scientists from The Third Way of Evolution), are pressing for significant textbook revisions and long-overdue updates to the foundations of biology. The group is shining a spotlight on two critical areas of education they say are inaccurate:

(1)  Darwin's finest insights are wrongly interpreted or overlooked;

(2)   17 transformational discoveries from molecular genetics and genome sequence data are omitted from biology's most used textbook.

They insist up-to-date evolution curriculum is key to rapid breakthroughs for treating disease and curing cancer. 

"Students are being taught outdated models," says Noble. "For a century, mainstream science taught fatalism – and insisted we're stuck with whatever genes we inherited from our parents. Today we know our bodies and cells are actually in charge of our own evolution; for instance, athletes transform the way genes express because exercise causes every cell to function differently – and some of this gets passed on across generations.

"The most valuable discoveries are not gene-centric, they are cell- and body-centric, yet we are ignoring this. It matters enormously whether we teach that we're merely passive vehicles for our genes vs. what we now understand – all living organisms are intentional creatures who can alter their genomes when it becomes necessary. It urgently needs rectifying."

More high-profile researchers agree, outdated curriculum has held back biomedical progress. "Scientists like Denis Noble and The Third Way are certainly right in demanding new textbooks on evolution," says Cambridge's Bernhard Strauss, chief editor of the book Rethinking Cancer. "Most books on evolution omit the most important cellular processes that actually drive evolution, particularly rapid adaptation and the ability to generate novel features. Teaching these concepts within Darwin's evolutionary framework will answer many currently unresolved questions in biology. It would also change our understanding of infectious diseases and ecology, and enable innovative approaches to explaining and treating cancer."

A new paper by Noble and a second with University of Chicago microbial geneticist James Shapiro, plus a Voices From Oxford video from Darwin's ancestral home, trace the history of distortions on Darwinism and offer crucial recommendations on how to correct:

  • In the first, most thorough published work of its Illusions of the Modern Synthesis, Noble recounts in detail the damage done to Darwin's legacy. He shows inaccuracies evolutionary theory has been saddled with in "Illusions of the Modern Synthesis" (March 2021). "Evolution is not passive or accidental," explains Noble. "Darwin suspected evolutionary change is engineered by the organism itself – and he was right. We pass on what we do and learn to offspring. Despite his predictions being censored and ignored, the record is irrefutable: evolution is intentional, not random."
  • Noble and Shapiro recently published "What Prevents Mainstream Evolutionists From Teaching the Whole Truth About How Genomes Evolve?" (May 2021). An accompanying infographic documents how popular evolution books are 30 years out of date and fail to report major discoveries in molecular biology and genomics which challenge the basic assumptions since Darwin's time, referred to as "Neo-Darwinism."
  • Noble hosted a roundtable video conversation from Darwin's home, Downe House, to highlight landmark findings textbooks failed to credit Darwin for including: Evolution occurs sometimes rapidly, other times hardly at all; organisms learn and transfer information to developing sperm and eggs. Darwin was scorned for his view and today's "Neo-Darwinism" continues to mistakenly teach "genetic fatalism."

Experts insist the science of epigenetics – that behaviors and environment cause changes affecting the way genes work – illustrates how impressive high-speed evolution takes place alongside slower, gradual alterations. "Our life experiences, like responses to stress, impact evolution from one generation to the next," explains John Torday, Professor of Evolutionary Medicine at UCLA. "A smoking grandmother alters the way DNA gets read without changing the genes themselves, and passes asthma to her granddaughter. We need to do a better job teaching this than we currently are."

Physician-scientists at the leading edge of treatment breakthroughs believe there will be significant benefits for diseases like cancer once curricula include contemporary knowledge. "Cancer cells resist radiation and chemotherapy via remarkable built-in evolutionary toolkits," says Columbia University oncologist Azra Raza, author of The First Cell. "They respond to threats at tremendous speed. It's time for textbooks to report this, and for practicing oncologists to factor this into patient treatment protocols."

Noble laments billions spent on the notion genes determine disease and health in a one-way, bottom-up framework in which humans have little control. "Genes are tools, not rigid programs," he adds. "Genes don't run cells any more than USB sticks run computers. This is great news. It gives us greater power over our own health. It's time to acknowledge the purpose and intentionality in our own bodies and through our own cells. It's time to focus on the empowerment that Darwin suspected and science now shows us is true. This is inexplicably missing in our education and training of next-generation scientists and physicians."

"Some of Darwin's finest theories were ignored, stifling breakthroughs for decades. But finally embracing them brings new approaches in so many diseases, perhaps even in generational health since we now suspect things like fetal alcohol syndrome and family trauma are passed down. Getting this rediscovery of history right – a "Darwin 2.0" – is about more than textbooks. Just imagine what happens when we finally tap into the adaptive power of the cell."

Further conversation with Noble can be found here: Denis Noble Q&A 

Natural Code is a private Investment group formed to identify a naturally occurring code. Its mission is to discover, develop and commercialize core principles of nature which give rise to information, consciousness and intelligence. Natural Code is sponsor of the largest award in basic science history.

Photo - https://mma.prnewswire.com/media/1583602/Natural_Code_denis_darwin_galapagos.jpg

PDF - https://mma.prnewswire.com/media/1583603/Natural_Code_popular_evolution_books.pdf

Related Links

evo2.org

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.